Proposition

3BP plans to establish additional collaborations with pharmaceutical partners in the area of peptide drug discovery and affinity purification ligands.
Collaborations can start at the level of peptide lead discovery or focus on the optimization of existing peptide structures.
The optimal allocation of discovery and preclinical development tasks between 3BP and its pharma partner can be individually mapped out for each project.

3BP offers exceptional value:

• In disease areas for which peptide approaches are particularly well-suited
• For projects where small molecule approaches on promising targets have failed
• For targets that are difficult to address with SMEs
• In targeted nuclear medicine and molecular imaging
• In generating and securing broad IP claims by data-supported patent strategies